A study shows continued increase in antibiotic resistance is not inevitable and offers new insights to help monitor drug ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

Thomas A. Russo, MD, SUNY Distinguished Professor and chief of infectious diseases at the Jacobs School, is co-author on a Nature Communications paper analyzing hypervirulent pneumoniae infections.

The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...

The emergence of antibiotic-resistant strains threatens to set back the world a hundred years to the age when even a minor ...

Antibiotic resistance is a growing threat. Empa's innovative sensors offer rapid detection of resistant pathogens, improving ...

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

Antibiotic resistance tends to stabilize over time, according to a study published in the open-access journal PLOS Pathogens ...